Diabetes meds may influence cancer outcomes in obese patients
NCT ID NCT07513259
First seen Apr 20, 2026 · Last updated May 23, 2026 · Updated 4 times
Summary
This study examined if the type of diabetes medication taken before a cancer diagnosis affects survival and complications after cancer in adults with obesity and type 2 diabetes. Researchers analyzed health records from over 200,000 people, comparing those who used GLP-1 receptor agonists to those on other diabetes drugs. The goal was to see if pre-diagnosis treatment is linked to outcomes like death or hospitalization, but this is an observational study, not a treatment trial.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DIABETES MELLITUS, TYPE 2 are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Chung Shan Medical University Hospital
Taichung, Taichung City, 402, Taiwan
Conditions
Explore the condition pages connected to this study.